Orange Book product · Generic (ANDA)
IOFLUPANE I-123
IOFLUPANE I-123
Generic (ANDA)ANDA 213792TE APRX CURIUM
At a glance
Mar 30, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 30, 2022
4 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
IOFLUPANE I-123
Strength
5mCi/2.5ML (2mCi/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 213792
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IOFLUPANE I-123
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
